Group One Trading
NVNO

Group One Trading’s enVVeno Medical NVNO Stock Holding History

Group One Trading’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-114
Closed -$3.62K – 8843
2025
Q3 		$3.62K Sell
114
-6,249
-98% -$638K ﹤0.01% 7691
2025
Q2 		$889K Buy
6,363
+6,334
+21,841% +$749K ﹤0.01% 2886
2025
Q1 		$2.63K Buy
+29
New +$3.23K ﹤0.01% 6906
2024
Q4 		– Sell
-54
Closed -$6.38K – 7745
2024
Q3 		$6.38K Sell
54
-4,375
-99% -$804K ﹤0.01% 5788
2024
Q2 		$814K Sell
4,429
-7,457
-63% -$1.3M ﹤0.01% 2164
2024
Q1 		$2.26M Buy
11,886
+840
+8% +$151K 0.01% 1398
2023
Q4 		$1.99M Buy
11,046
+7,009
+174% +$1.12M 0.01% 1885
2023
Q3 		$762K Buy
+4,037
New +$673K ﹤0.01% 2531
2023
Q1 		– Sell
-3,300
Closed -$589K – 7705
2022
Q4 		$589K Sell
3,300
-1,594
-33% -$324K ﹤0.01% 2894
2022
Q3 		$1.08M Buy
4,894
+2,383
+95% +$507K ﹤0.01% 2511
2022
Q2 		$332K Buy
2,511
+514
+26% +$79.7K ﹤0.01% 3819
2022
Q1 		$445K Buy
1,997
+960
+93% +$186K ﹤0.01% 3938
2021
Q4 		$239K Buy
+1,037
New +$292K ﹤0.01% 4914

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading's NVNO Position: Q1 2026 in Review

Group One Trading reduced its enVVeno Medical (NVNO) stake by 96% in Q1 2026, selling an estimated $525 and leaving 2 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #7461.

Group One Trading first reported a position in NVNO in Q3 2023 and has held it in 6 quarters since. The position peaked at $34.3K in Q3 2023. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Group One Trading held 2 shares of enVVeno Medical worth $20 as of Q1 2026.
  • Group One Trading sold 48 enVVeno Medical shares in Q1 2026, an estimated $525.
  • enVVeno Medical made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7461 holding.
  • Group One Trading first reported a position in enVVeno Medical in Q3 2023 and has held it in 6 quarters since.
  • Group One Trading's enVVeno Medical position peaked at $34.3K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.